Intranasal Triamcinolone Use during Pregnancy and the Risk of Adverse Pregnancy Outcomes

被引：0
|
作者：
Berard, Anick
Sheehy, Odile
Kurzinger, Marie-Laure
Juhaeri, Juhaeri
机构：
[1] CHU Ste Justine, Montreal, PQ, Canada
[2] Univ Montreal, Montreal, PQ, Canada
[3] Sanofi, Global Pharmacovigilance & Epidemiol, R&D, Paris, France
[4] Sanofi, R&D, Global Pharmacovigilance & Epidemiol, Bridgewater, MA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
448
引用
收藏
页码：255 / 255
页数：1
相关论文
共 50 条
  • [1] Intranasal Triamcinolone Use during Pregnancy and the Risk of Adverse Pregnancy Outcomes
    Berard, A. B.
    Sheehy, O. S.
    Kurzinger, M. L. K.
    Juhaeri, J. J.
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2015, 103 (05) : 410 - 410
  • [2] Intranasal triamcinolone use during pregnancy and the risk of adverse pregnancy outcomes
    Berard, Anick
    Sheehy, Odile
    Kurzinger, Marie-Laure
    Juhaeri, Juhaeri
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (01) : 97 - +
  • [3] Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes
    Rebordosa, Cristina
    Kogevinas, Manolis
    Bech, Bodil H.
    Sorensen, Henrik T.
    Olsen, Jorn
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2009, 38 (03) : 706 - 714
  • [4] Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes
    Berard, Anick
    Zhao, Jin-Ping
    Shui, Irene
    Colilla, Susan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (04) : 500 - 509
  • [5] Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes
    Anick Bérard
    Shannon Strom
    Jin-Ping Zhao
    Shashi Kori
    Detlef Albrecht
    [J]. Scientific Reports, 11
  • [6] Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes
    Berard, Anick
    Strom, Shannon
    Zhao, Jin-Ping
    Kori, Shashi
    Albrecht, Detlef
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Partner violence during pregnancy and risk of adverse pregnancy outcomes
    Coker, AL
    Sanderson, M
    Dong, B
    [J]. PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2004, 18 (04) : 260 - 269
  • [8] Dihydroergotamine (DHE) Use during Gestation and the Risk of Adverse Pregnancy Outcomes
    Berard, A.
    Sheehy, O.
    Kori, S. H.
    [J]. HEADACHE, 2011, 51 : 39 - 39
  • [9] Dihydroergotamine (DHE) Use during Gestation and the Risk of Adverse Pregnancy Outcomes
    Berard, A.
    Sheehy, O.
    Kori, S.
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2011, 91 (05) : 352 - 352
  • [10] Dihydroergotamine (DHE) Use During Gestation and the Risk of Adverse Pregnancy Outcomes
    Berard, Anick
    Kori, Shashidhar
    [J]. HEADACHE, 2012, 52 (07): : 1085 - 1093
12345